KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of GoodwillAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Teladoc Health (TDOC) Free Cash Flow (2016 - 2025)

Historic Free Cash Flow for Teladoc Health (TDOC) over the last 12 years, with Q3 2025 value amounting to $70.2 million.

  • Teladoc Health's Free Cash Flow fell 1289.69% to $70.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $182.1 million, marking a year-over-year decrease of 1448.97%. This contributed to the annual value of $180.4 million for FY2024, which is 1205.0% down from last year.
  • As of Q3 2025, Teladoc Health's Free Cash Flow stood at $70.2 million, which was down 1289.69% from $62.5 million recorded in Q2 2025.
  • Teladoc Health's Free Cash Flow's 5-year high stood at $95.0 million during Q4 2023, with a 5-year trough of -$58.7 million in Q1 2022.
  • Over the past 5 years, Teladoc Health's median Free Cash Flow value was $62.4 million (recorded in 2024), while the average stood at $35.6 million.
  • In the last 5 years, Teladoc Health's Free Cash Flow crashed by 25203.96% in 2021 and then surged by 43200.58% in 2023.
  • Over the past 5 years, Teladoc Health's Free Cash Flow (Quarter) stood at $63.2 million in 2021, then tumbled by 71.76% to $17.9 million in 2022, then soared by 432.01% to $95.0 million in 2023, then plummeted by 34.31% to $62.4 million in 2024, then rose by 12.56% to $70.2 million in 2025.
  • Its Free Cash Flow was $70.2 million in Q3 2025, compared to $62.5 million in Q2 2025 and -$12.9 million in Q1 2025.